title: Everolimus versus sirolimus-eluting stents for the treatment of sirolimus-eluting stent restenosis.
authors.forename: Rong-Qiang
authors.initials: RQ
authors.lastname: Yan
authors.forename: Li-Jian
authors.initials: LJ
authors.lastname: Gao
authors.forename: Ji-Lin
authors.initials: JL
authors.lastname: Chen
mesh_terms: D000368:Aged; D023903:Coronary Restenosis / Q000139:chemically induced / Q000188:drug therapy*; D054855:Drug-Eluting Stents / Q000009:adverse effects; D000068338:Everolimus; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D020123:Sirolimus / Q000008:administration & dosage* / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D007166:Immunosuppressive Agents; D000068338:Everolimus; D020123:Sirolimus